Navigation Links
Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.
Date:3/19/2013

NEW YORK, March 19, 2013 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ: SPPI), concerning whether the board has breached its fiduciary duties to shareholders.

(Logo:  http://photos.prnewswire.com/prnh/20120215/MM54604LOGO )

On March 12, 2013, the Company announced that sales of its drug, FUSILEV, would be significantly lower during 2013 due to changes in market demand for FUSILEV.  As a result, the Company decreased its 2013 revenue guidance from approximately $300 million to as low as $160 million.On this news, Spectrum shares lost more than 35% of their value in one day of trading to close at $7.79 per share on March 13, 2013, down from $12.43 per share at close on March 12, 2013.

Our investigation concerns whether the Company board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, and/or committed abuses of control in connection with the foregoing.

If you own Spectrum shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:Robert I. Harwood, Esq.Matthew M. Houston, Esq.Benjamin I. Sachs-Michaels, Esq.Harwood Feffer LLP488 Madison AvenueNew York, New York 10022Phone Numbers:

(877) 935-7400(212)935-7400Email:  bsachsmichaels@hfesq.comWebsite:
http://www.hfesq.com Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.

Attorney Advertising. © 2013 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

 


'/>"/>
SOURCE Harwood Feffer LLP
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Harwood Feffer LLP Announces Investigation of MAP Pharmaceuticals, Inc.
2. Harwood Feffer LLP Announces Investigation of DUSA Pharmaceuticals, Inc.
3. Harwood Feffer LLP Announces Investigation of PSS World Medical, Inc.
4. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
5. EGEN, Inc. Announces a Phase I Clinical Trial for Advanced Ovarian Cancer
6. National Minority Quality Forum Announces Support for Government Noninterference in Drug Price Negotiations
7. MGC Diagnostics Corporation Announces Worldwide Exclusive Distribution Partnership with Restech Respiratory Technology
8. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
9. BioElectronics Announces Chronic and Postoperative Wound Care Product Distribution in Italy
10. Athena Diagnostics Announces New Genetic Testing Services for Rare Neurological Disorders
11. Precision Optics Corporation Announces Reciept Of $660,000 Purchase Order For Custom-Designed Endoscopes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... 27, 2017  Commended for their devotion to personalized service, ... as number one in the South Florida Business Journal,s 50 ... 5000 yearly list, the national specialty pharmacy has found its ... will soon be honored by SFBJ as the 2017 ... Set to receive his award in October, Bardisa said ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical (AVACEN) ... is now successfully helping those with the widespread pain ... Fibromyalgia diagnosed Amanda in Essex, England ... washing my hair, experiencing no sleep at all, tremendous ... spasm… I cannot recommend [the AVACEN 100] enough, how ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Ellevate Network, ... in business to advocate for action towards gender equality at their inaugural Summit in ... around the globe, and reached a social audience of over 3 million. To watch ...
(Date:10/13/2017)... ... 2017 , ... Coveros, a leader in agile coaching services ... by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile Transformation ... Agile methodologies in a consistent and high value manner across CMS programs. Coveros ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... , ... October 12, 2017 , ... The American College ... to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in ... , In honor of Morris F. Collen, a pioneer in the field of medical ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
Breaking Medicine News(10 mins):